Literature DB >> 25852779

Psychomotor functions at various weeks of chronic renal failure in rats.

Merin Iype Chandanathil1, Subramanya Upadhya2, Sharmila Upadhya3, Gopalakrishna Bhat4.   

Abstract

In chronic renal failure there is a gradual retention of substances in the tissues and body fluids, called as uremic retention toxins, which can bring about a number of biochemical activities in the body. Chronic renal insufficiency also leads to progressive behavioural conflict. Uremic toxins can affect both the central and the peripheral nervous system. Uremic encephalopathy is also associated with problems in cognition and memory. To study the psychomotor functional disorders in rats with progressive chronic renal failure surgical nephrectomy was done by resection method. The animals were grouped into two control groups, Sham control (SC) and normal control (NC) and two uremic groups, moderate uremia (GM) and severe uremia (GS). Psychomotor analysis was done by passive avoidance and open field in these animals at 4, 8, 12, and 16 weeks. After the incubation period, the nephrectomised groups (GM and GS) showed significant changes in exploratory, locomotor and emotional behaviour when compared to the controls (NC and SC). Psychomotor changes involve poor cognition, reduced memory, reduced locomotor activity and decreased exploratory drive and emotional disturbance like increased fear during the initial stages. During the later stages a restless behaviour was noticed, associated with diminished fear.

Entities:  

Keywords:  Nephrectomy; Psychomotor; Renal insufficiency; Uremic toxins

Year:  2014        PMID: 25852779      PMCID: PMC4378555          DOI: 10.1007/s11571-014-9315-z

Source DB:  PubMed          Journal:  Cogn Neurodyn        ISSN: 1871-4080            Impact factor:   5.082


  41 in total

1.  Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.

Authors:  K C Berridge; J W Aldridge
Journal:  Synapse       Date:  2000-09-01       Impact factor: 2.562

2.  The amygdala modulates memory consolidation of fear-motivated inhibitory avoidance learning but not classical fear conditioning.

Authors:  A E Wilensky; G E Schafe; J E LeDoux
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

3.  Separation of activation and pattern in grooming development of weaver mice.

Authors:  V J Bolivar; W Danilchuk; J C Fentress
Journal:  Behav Brain Res       Date:  1996-02       Impact factor: 3.332

4.  Inhibition of grooming by pilocarpine differs in high- and low-yawning sublines of Sprague-Dawley rats.

Authors:  J R Eguibar; A Moyaho
Journal:  Pharmacol Biochem Behav       Date:  1997-10       Impact factor: 3.533

5.  Modulating effects of posttraining epinephrine on memory: involvement of the amygdala noradrenergic system.

Authors:  K C Liang; R G Juler; J L McGaugh
Journal:  Brain Res       Date:  1986-03-12       Impact factor: 3.252

6.  Preferential impairment of avoidance performances in amygdala-lesioned mice.

Authors:  K Takashina; H Saito; N Nishiyama
Journal:  Jpn J Pharmacol       Date:  1995-02

7.  Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study.

Authors:  Manjula Kurella; Glenn M Chertow; Linda F Fried; Steven R Cummings; Tamara Harris; Eleanor Simonsick; Suzanne Satterfield; Hilsa Ayonayon; Kristine Yaffe
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

8.  Involvement of amygdala pathways in the influence of post-training intra-amygdala norepinephrine and peripheral epinephrine on memory storage.

Authors:  K C Liang; J L McGaugh; H Y Yao
Journal:  Brain Res       Date:  1990-02-05       Impact factor: 3.252

Review 9.  Nervous system complications in uremia.

Authors:  C L Fraser; A I Arieff
Journal:  Ann Intern Med       Date:  1988-07-15       Impact factor: 25.391

10.  Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.

Authors:  M Pestana; H Jardim; P Serrão; P Soares-da-Silva; L Guerra
Journal:  Kidney Blood Press Res       Date:  1998       Impact factor: 2.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.